Manufacturer copay assistance · Entyvio (J3380) · Takeda
Eligible patients pay as… · Maximum benefit Up to $20,000/year · Covers Entyvio drug cost only — does not cover infusion administration
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Entyvio — the program's cap applies against the patient share CareCost calculates.
Yes — EntyvioConnect Co-pay Program from Takeda. Eligible patients pay as little as $0 per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay as little as $0 per dose Maximum benefit: Up to $20,000/year. Covers Entyvio drug cost only — does not cover infusion administration
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.